News & Updates
Filter by Specialty:
Vedolizumab helps induce steroid-free remission in children with IBD
Use of vedolizumab as maintenance treatment in children with inflammatory bowel disease (IBD) results in sustained steroid-free remission, with an acceptable safety profile, according to the results of the 54-week follow-up of the VedoKids Study presented at ESPGHAN 2024.
Vedolizumab helps induce steroid-free remission in children with IBD
21 May 2024Infants, children with comorbidities at greatest risk for critical COVID-19
The risk of critical COVID-19 is highest among infants and adolescents, children with multiple comorbidities, those with a history of prematurity, diabetes, obesity, severe immunocompromise, and those with cardiovascular, neurologic, or chronic lung diseases, reveals a study presented at PAS 2024.
Infants, children with comorbidities at greatest risk for critical COVID-19
21 May 2024Hypertension puts kids at risk of long-term cardiac events
Children who have hypertension are more likely to experience adverse cardiovascular outcomes in the future than those without high blood pressure (BP), according to a study presented at PAS 2024.